Duplication 15q syndrome (Dup15q) is a rare neurogenetic disorder characterized by autistic features and difficult to control (pharmacoresistant) epileptic seizures. Most individuals with isodicentric (idic15) have been on multiple medications to control their seizures and some are still seizing after years of treatment. We recently developed a model of Dup15q in Drosophila by elevating levels of fly Dube3a in glial cells, not neurons.
Introduction
Chromosomal deletions and duplications of the 15q11.2-q13.1 region cause some of the most devastating neurogenetic syndromes in humans, including Angelman syndrome (AS), Prader-Willi syndrome (PWS) and one of the most common genetic abnormalities leading to autism spectrum disorder (ASD), Duplication 15q syndrome (Dup15q) (1) . In fact, duplications of 15q are often found in clinical cohorts of ASD, mostly isodicentric duplications of 15q which result in four copies of the genomic region containing the imprinted gene UBE3A (2) . Multiple lines of evidence from both human genetic studies and experimental models suggest a tight regulation of UBE3A expression in the mammalian brain, resulting in maternal allele specific expression of UBE3A in neurons of the brain (3) (4) (5) . In AS, loss of the maternal UBE3A allele through 15q11.2-q13.1 deletions, mutations of maternal UBE3A or paternal uniparental disomy for the locus all result in an AS phenotype (6) . While some evidence suggests that maternal, but not paternal, duplications of 15q result in ASD phenotypes, implicating the maternal expression of UBE3A in neurons (7, 8) , there is still not definitive proof from murine models that this is the case (9) . Furthermore, multiple studies focused on maternal expression of Ube3a in mouse neurons have failed to recapitulate the common and severe pharmacoresistant epilepsy phenotype shared by most isodicentric Dup15q individuals (9) (10) (11) (12) .
A common co-incident phenotype in ASD is an increased incidence of epileptic seizures (13) (14) (15) . Although the most prominent feature of Dup15q syndrome is ASD and behavioral abnormalities, most individuals with idic15 also suffer from difficult to control seizures (pharmacoresistant) (1, 16) . Typically individuals with idic15 have been on several medications to control their seizures and some individuals continue to suffer from epilepsy despite several anti-epileptic drugs available which can control seizures in AS or even epilepsy of unknown genetic origin. Parent reporting indicates that these pharmacoresistant seizures are the most difficult issue to address in the Dup15q population (16) .
Our lab recently developed a model of Dup15q syndrome in Drosophila melanogaster which recapitulates the seizure phenotype seen in humans (17) . We showed that glial expression, but not neuronal expression, of Dube3a (the fly UBE3A orthologue) results in a robust and reproducible seizure phenotype in flies (17) . Although there are currently several mouse models of Dup15q syndrome which elevate Ube3a levels in neurons, none of these mouse models show a spontaneous or easy to induce seizure phenotype like our Drosophila model. In fact, flies expressing Dube3a or human UBE3A in glial cells will show seizure phenotypes after vortexing, at elevated temperatures or even through optical stimulation using a strobe light (17) .
Several lines of evidence from both murine models and human brain studies indicate that the UBE3A gene escapes allele specific expression in glial cells of the mammalian brain. Early studies of imprinting in cultured neurons or glia from Ube3a maternal allele deficient mice indicated that not only is Ube3a expressed from the paternal allele in cultured glia, but that the Ube3a antisense transcript, which regulates Ube3a expression on the paternal allele, could not be detected in cultured glia from Ube3a M-/P+ animals (18) . Additional studies in the mouse brain showed that Ube3a escapes allele specific regulation in GFAP+ glial cells and oligodendrocytes of the brain (19, 20) . Finally, studies utilizing a Ube3a-YFP knock in construct further validated the finding that Ube3a is bi-allelically expressed in glial cells (21) . Recently, a study using human brain samples confirmed at the protein level that UBE3A is present in GFAP+ glial cells of the human brain (19) .
Given the body of evidence supporting biallelic expression of UBE3A in glia and the hypothesis that biallelically expressed UBE3A in glial cells should be elevated in idic15 individuals who have 4 copies of UBE3A, we initiated a screen using our new fly model of Dup15q to identify small molecules that could suppress seizures and reveal mechanisms through which elevated UBE3A in glia could result in a seizure phenotype.
Here we exploited a 30 second window of paralysis observed in all flies expressing Dube3a in glia to design a screen for small molecules that can suppress seizures in an effort to identify previously approved drugs that can be repurposed to potentially treat seizures in humans with Dup15q.
Methods and Materials

Fly Stocks
All flies were maintained at 25°C on a 12-hour light/dark cycle and raised on standard corn meal media (Bloomington Stock Center). The following stocks were obtained from (22) . The Dube3a and human UBE3A UAS lines used in this study have been described previously (23) . A complete list of stocks used can be found in Table S2 .
Chemical Compound Preparation
The Prestwick Library of 1280 approved drugs was purchased from Prestwick Chemicals (Illkirch, France). This library has high chemical and pharmacological diversity with known bioavailability and safety in humans. All compounds were dissolved in DMSO (Sigma-Aldrich; St. Louis, MO) and mixed with standard corn meal medium to make drug food (0.1% final DMSO concentration; Drug Concentration: 1µM) for the primary screening.
For the secondary screening and the other pharmacological interventions, drugs were dissolved in water, ethanol or DMSO (based on their highest solubility) and mixed with standard corn meal medium to make drug food (DMSO concentration used: 0.02% in all drug food except for Ceforanide = 0.05%). Drugs were serially diluted to concentrations: 0.04µM, 0.2µM, 1.0µM and 5.0µM depending on the experiment.
Primary Seizure Susceptibility Screen
For all behavior tests, flies were not exposed to CO2 for at least two days prior to testing to avoid issues related to seizure resistance after exposure to CO2. The bang sensitivity assay (BSA) was performed as previously described (24) (25) (26) . Both drug and non-drug (DMSO alone) fed flies were transferred to empty standard fly vials and subjected to mechanical stress ("bang") by vortexing the vial at full speed on a standard laboratory vortexer (LabNet) for 10 seconds. After vortexing, but within a 30 second critical window, the flies were separated (seizing from non-seizing) using the apparatus described in Figure 1B . This apparatus was constructed by placing a funnel over a falcon tube cut at both ends and placed on top of a Petri dish without a lid. The funnel was subsequently removed and replaced with an empty vial. A timer was started and after 30 seconds, the Petri dish containing the immobile seizing flies was covered with the lid. Subsequently, the falcon tube -empty vial was flipped to transfer all the non-seizing flies into the empty vial. Flies of both the genotypes: repo>Dube3a and UAS-Dube3a;TM3,Sb were counted in the seizure group (Petri dish) and the non-seizure group (empty vial over the falcon tube). Since seizure was induced only in the repo>Dube3a flies, we used these counts in the final analysis of drug induced seizure recovery. For all the experiments in the primary screen we used 3 -4 day old flies.
Secondary Validation Seizure Assays
Based on our previous study of glial initiated seizures, we used 4 day old repo>Dube3a and 9 day old repo>UBE3A flies (17) in subsequent experiments. For all behavior tests, flies were sorted and separated at least two days prior to testing to avoid complications from CO2 anaesthesia. Flies of each genotype, repo>Dube3a or repo>UBE3A (both with and without drug) were sorted by sex post eclosion and transferred to freshly prepared drug containing food or solvent-only food.
For seizure behavior studies, flies were anesthetized briefly by exposing the vials to ice for 2-3 minutes. Then 3-5 flies were distributed to empty vials for the bang sensitivity assay. After a 1-hour recovery from cold-anesthesia, the flies were subjected to mechanical stress ("bang") by vortexing the vial using a standard laboratory vortexer (LabNet) at top speed for 10 seconds. The total recovery time was recorded for each individual fly in the vial using a digital timer. Total recovery time in our assay was defined as the time taken by a fly to fully recover (i.e. when the fly righted itself and was able to walk freely around on the base or on the walls of the vial). For each drug at each concentration, or combination of drugs, at least 40 flies of the correct genotype were tested in the bang sensitivity assay. oil immersion lens using the N3 and L5 filters for tdTomato and APG-2 respectively.
Glial Cell K + Content Assay
Exposure times were calibrated on repo>tdTomato brains and microscope settings remained constant between repo>tdTomato and repo>Dube3a+tdTomato groups to allow for direct comparison of fluorescence intensity. APG-2 fluorescence intensity was calculated offline using Adobe Photoshop CC2018 and ImageJ (27) . The APG-2 channel was converted to a gray scale image using Adobe Photoshop. Brightness and contrast parameters were kept constant in all images across various groups. Only tdTomatopositive glial cells were selected for analysis. Cells were selected using the "freeform" tool to outline the cell body in the APG-2 channel. Using the "measure" command, the mean fluorescence value for each cell was recorded as previous described (17) . A minimum of 35 cells was analyzed per group from at least 3 images each from 3 different brains per group.
Statistical Analysis and Graphing
All graphs and statistical tests were performed using Prism version 7.0 (GraphPad). All histograms and measurements are shown as mean ± SEM. To test for statistical significance between two samples, Student's t-test with two tailed comparison was used.
To determine statistical significance among multiple samples, we used a one-way ANOVA with Tukey's multiple comparison correction. Statistical significance is indicated on all graphs by convention: pvalue ≤ 0.05 (*), pvalue ≤ 0.01 (**), pvalue ≤ 0.001 (***) and pvalue ≤ 0.0001 (****). All analyses were performed with the experimenter blinded to genotype.
Results
In a previous study, we determined that glial expression of fly Dube3a using the pan-glial driver repo-GAL4 results in a bang sensitive phenotype, i.e. seizures after vortexing. In addition, we found that pan-neuronal expression using elav-GAL4 or expression of a ubiquitin ligase defective form of Dube3a did not evoke seizures (17) . These studies also revealed a 30 second window after vortexing wherein 100% of repo>Dube3a animals were in the paralysis phase ( Figure 1A) . We designed a new screening method based on exploiting this 30 second window of paralysis to separate flies that are not seizing from flies that are seizing. Flies that are seizing will fall to the bottom of the tube after vortexing, but flies that are not seizing, have very short seizure recovery times, or are not the repo>Dube3a genotype, will crawl towards the top of the tube and can be collected separately ( Figure 1B) . Each group of flies is then evaluated visually under the microscope to identify only repo>Dube3a flies in each group for scoring. For the drug screen, we used the Prestwick Chemical Library (Prestwick Chemical) of 1280 off-patent small molecules previously approved for use in humans. Food was prepared containing 1µM of each compound plus DMSO only controls. Flies were grown at 25°C on drug containing food from embryos and tested in the modified bang sensitivity screen 3-5 days after eclosion.
Primary and Secondary Screening and Validation Assays Reveals 8 Candidate
Compounds for Seizure Suppression
Our primary screening selection criteria for compounds that could suppress seizure activity was that compounds must suppress seizures in at least 25% of the repo>Dube3a animals within the 30s collection window. Using these criteria, we identified 17 compounds that could suppress seizures in repo>Dube3a animals that eclosed from triplicate crosses ( Table 1) . We immediately noted that 5 out of 17 compounds, which passed primary screening, were related in some way to serotonin (serotonin hydrochloride (5HT), mirtazapine and minaprine dihydrochloride) or dopamine (minaprine dihydrochloride, levodopa (L-dopa) and prenylamine lactate) signaling.
Validation of the 17 primary screen compounds was performed using a more accurate bang sensitivity assay with individual flies and measuring the actual seizure recovery times. All 17 compounds were also tested at 5µM, 1µM, 0.2µM and 0.04µM concentrations in order to identify the lowest concentration that was still effective at seizure suppression and in the appropriate solvent (DMSO, water or EtOH depending on the compound). While there were no differences in seizure activity across these different solvents, we did note a difference in variance in male flies versus female repo>Dube3a flies ( Figure S1 ). For this reason, we tested both males and females separately for the validation assays.
The go/no go criteria for validation of a primary screen candidate was as follows:
the compound must suppress seizures by at least a 50% decrease in recovery time versus solvent alone at one of the tested concentrations; 2) the suppression must reach a statistical significance by one-way ANOVA of at least pvalue < 0.01; 3) the suppression must occur in both males and females. Using these criteria we were able to identify 8/17
primary screen candidates that can suppress seizures in repo>Dube3a males and females (Figure 2 ). Using these stringent criteria we found that most of the compounds could suppress seizures by 50% in males and females at a concentration of 0.04µM in the food (the exception being Iopamidol, which required 1µM and both levodopa and dorzolamide hydrochloride which both required at least 0.2µM for suppression). A complete list of these compounds and their approved uses in humans can be found in Table S1 . Drugs that failed the secondary validation can be found in Figure S2 .
Once again, the five compounds involved in serotonin and dopamine signaling identified in the primary screen which were able to reach significance included 5HT, mirtazapine, minaprine dihydrochloride, prenylamine lactate and L-Dopa. The relationship among the three serotonin signaling compounds provided clues to the mechanism of action of seizure suppression. Serotonin can stimulate 5-HT1, 5-HT2, 5-HT3 and 5-HT4,5,6,7 receptors, but mirtazapine is a strong antagonist of all serotonin receptors except 5-HT1A (28) (29) (30) (31) . Minaprine dihydrochloride is a serotonin and dopamine re-uptake inhibitor, and can therefore increase the levels of free serotonin and dopamine at the synapse (32) . Another drug, prenylamine lactate, is known to prevent noradrenaline and dopamine from reuptake by storage granules, thereby increasing their concentration in the synaptic cleft (33, 34) . Thus, both minaprine dihydrochloride and prenylamine lactate could possibly increase serotonin and dopamine levels at the synapse, which is consistent with the observation that levodopa can also suppress seizures in addition to serotonin (Figure 2) . Additional information about these drugs can be obtained from In order to support this pharmacological data with genetic evidence, we acquired several mutants in various components of the serotonin and dopamine synthesis pathways and one mutant involved in dopamine re-uptake, available from the Bloomington Stock Center. The synthesis of both serotonin and dopamine is linked in both flies and humans via an enzymatic pathway that contains three enzymes.
Tryptophan hydroxylase (Trh in flies) is the first enzymatic step in the conversion of (Figure 3C) . These data suggest that more dopamine in the synaptic space has a therapeutic effect on seizures produced by elevated Dube3a in glia.
In combination with the neurotransmitter synthesis data, these genetic studies fully support the pharmacological studies which suggest stimulation of serotonin and/or dopamine pathways can significantly suppress seizures in our model.
Specific Stimulation of 5-HT1A Receptor Alone Suppresses Seizures in Repo>Dube3a
Flies
Since both serotonin, which stimulates all serotonin receptors, and mirtazapine, which is an antagonist of all serotonin receptors except 5-HT1A, were both able to suppress seizures in repo>Dube3a flies, we decided to broaden our analysis using a series of specific serotonin receptor agonists and antagonists for their ability to suppress or enhance seizures in order to address the hypothesis that stimulation of 5-HT1A alone can suppress seizures. Table 2 lists specific 5-HT receptor agonists and antagonists, as well as the predicted result if we feed repo>Dube3a animals these compounds and test for seizure activity. Two 5-HT1A agonists (serotonin hydrochloride and U92016A), two 5-HT1A
antagonists (WAY100635 and mianserin HCl), one 5-HT2A antagonist (ketanserin tartrate) and one agonist for 5-HT2A,2B,2C, but not 5-HT1 (https://www.wikidata.org), were assayed for their ability to suppress or enhance seizures at concentrations from 0.04µM to 5µM.
All drugs that stimulated 5-HT1A, directly or indirectly, were able to suppress seizures at concentrations down to 0.04µM in the food (Figure 4A ). All compounds that either directly or indirectly routed serotonin away from 5-HT1A increased the seizure recovery times significantly in repo>Dube3a animals at concentrations ranging from 0.04µM to 1µM in the food (Figure 4B) . In fact, these same agonists and antagonists had identical effects on seizures in 9 day old flies expressing human UBE3A in glia at identical dosages that were effective in animals expressing fly Dube3a in glia (Figure 5) . Together, these results indicate that stimulation of 5-HT1A, or inhibition of 5-HT2A in the presence of active 5-HT1A, can pharmacologically suppress seizures generated in glia by over-expression of either fly or human UBE3A.
In order to support these pharmacological findings, we performed genetic experiments designed to determine if serotonin could still suppress seizures in repo>Dube3a flies in a 5-HT1A or 5-HT2A mutant background. Loss of function alleles of both 5-HT1A(5HT1A D5kb ) or 5-HT2A(5-HT2A C1644 ) receptors were identified in the BDSC which were then crossed to a stock containing both repo-GAL4 and UAS-Dube3a over Xap (w 1118 ; [repo-GAL4;UAS-Dube3a]/Xap). As expected, loss of 5-HT1A significantly increased seizure recovery time in repo>Dube3a animals, but loss of 5-HT2A had no effect ( Figure 6A) . There was also a noticeable shift in transcript expression from 5-HT1A to 5-HT2A in repo>Dube3a flies vs control animals (Figure 6B) . Although the pharmacological data indicated that inhibition of 5-HT2A can also suppress seizures, these genetic experiments show that the 5-HT2A receptor itself is not involved in seizure suppression, suggesting that inhibition of 5-HT2A pharmacologically simply frees up more serotonin in the synaptic space which can then stimulate the 5-HT1A to suppress seizures.
In a previous study, we showed that glial overexpression of Dube3a causes seizures and synaptic impairments in Drosophila concomitant with down regulation of the Na + /K + pump ATPα (17) . Serotonin and dopamine are known activators of glial or astrocytic Na + /K + pump ATPα via adenyl cyclase dependent protein kinase A (PKA) signaling (35) (36) (37) . In order to understand the mechanism underlying serotonin or dopamine mediated seizure suppression in repo>Dube3a flies, we fed serotonin or dopamine to flies co-expressing ATPα, which we previously showed could partially rescue seizures (17) . We found that either serotonin or dopamine suppressed seizures more effectively in flies co-expressing ATPα and Dube3a, than flies expressing either ATPα + Dube3a (without drug) or Dube3a (with drug) (Figure 7A-B) . Finally, adding a cocktail of both serotonin and dopamine while co-expressing ATPα almost completely suppressed seizures in repo>Dube3a flies (Figure 7C) .
The function of ATPα is to pump K + into the cell while pumping Na + into the extracellular space in an ATP-dependent manner. Previously, we showed that elevated Dube3a levels within glia reduce internal K + , consistent with the hypothesis that Dube3a down regulates ATPα levels causing a disruption of Na + /K + homeostasis (17) . We dissected whole brains from repo>tdTomato, repo>tdTomato + Dube3a,repo>tdTomato + Dube3a (fed 5HT) and repo>tdTomato + Dube3a (fed L-dopa) animals in order to visualize K + concentrations within glia. Brains were incubated in a cell-permeable fluorescent K + indicator called Asante Potassium Green 2 AM (APG-2) as in our prior study (17) . Quantification of the fluorescence intensity of APG-2 in tdTomato + cells is an indicator of the relative concentration of K + in glial cells across all genotypes. As expected, there was a significant reduction in APG-2 fluorescence in repo>tdTomato + Dube3a compared to control repo>tdTomato glial cells (Figure 8) . However, the addition of a serotonin + L-dopa cocktail restored the concentration of K + within the tdTomato + glial cells ( Figure 8C) . These data suggest that 5HT and L-dopa can modulate ATPα activity in glia, restoring intercellular K + levels, and thereby maintaining the ionic homeostasis at the synapse.
Discussion
A Role for Serotonin Signaling in Dup15q Seizure Suppression
Epilepsy is a common co-morbidity with ASD in general (15, (38) (39) (40) (41) (42) (43) , but can be even more severe and difficult to treat in syndromic forms of ASD like Dup15q syndrome (1, 16, 44, 45) . In fact, most children with isodicentric duplications of 15q that include four copies of the UBE3A gene, presumably active in glia where it is not imprinted (18) (19) (20) (21) , suffer from pharmacoresistant seizures (16) . Here we utilized our fly model of Dup15q to screen for previously approved compounds that can suppress seizures due to elevated levels of UBE3A in glia, not neurons (17) . We identified 8 compounds that could significantly suppress these gliopathic seizures in both males and females. Surprisingly, five of these compounds (serotonin, levodopa, mirtazapine, prenylamine and minaprine dihydrochloride) are specifically related to serotonin and dopamine signaling. We show that this signaling is preferentially through stimulation of serotonin 5-HT1A receptors, although we are still not sure which specific dopamine receptors may be involved in seizure suppression. The pharmacological and genetic data presented here strongly suggest that specific agonists of 5-HT1A used to treat depression, for example the drug vortioxetine, could potentially be strong suppressors of seizure activity in Dup15q individuals.
A Possible Mechanism for Seizure Suppression
We found that inhibition of or heterozygous mutations in 5-HT2A alone do not influence seizure susceptibility in repo>Dube3a flies (Figure 6A) . One explanation is that in the presence of 5-HT2A antagonists or background mutations in 5-HT2A receptor, free serotonin is still able to suppress seizures in repo>Dube3a flies through 5-HT1A.Cross talk between 5-HT1A and 5-HT2A receptors has been documented in the mammalian brain previously (46) . Our own transcript expression studies here indicate that overexpression of Dube3a simultaneously down regulates 5HT1A receptor and up regulates 5HT2A receptor expression ( Figure 6B) .
We have also shown, using both genetic and pharmacological manipulations, that both serotonin and dopamine are able to suppress seizures in repo>Dube3a flies.
In a previous study, we showed that glial overexpression of Dube3a causes seizures and synaptic impairments in Drosophila concomitant with down-regulation, at the protein level, of the Na + /K + pump ATPα (17, 47) . Serotonin modulates glial Na + /K + -ATPase activity in the rat cerebral cortex and hippocampus, through the 5-HT1A receptor signalling (37) . In addition, dopamine activates Na + /K + -ATPases and Mg 2+ -ATPases in the presence of the brain enriched soluble fraction of the rat cerebral cortex (48) . Using behavioral and live imaging data assaying glial cell K + content, we show here that both serotonin and dopamine suppress seizures by modulating Na + /K + -ATPase activity, despite the decrease in overall ATPα protein levels, possibly though the activation of ATPα via PKA phosphorylation. A massive influx of K + ions into glia helps to restore the action potential to basal levels, and suppress seizures. Our new model proposes that serotonin and dopamine can reduce neuronal hyperexcitability by activation of PKA in glia, which in turn, activates the residual ATPα not degraded by Dube3a, and restores the basal levels of K + ions in the synaptic cleft (Figure 9 ).
Compounds Unrelated to Serotonin or Dopamine that Can Suppress Seizures
The compound screen we conducted also yielded some other potential seizure suppressors unrelated to serotonin or dopamine signaling. Even though we mainly focused on serotonin and dopamine for our mechanistic studies, these other hits are interesting as well since they regulate seizure activity via complementary mechanisms, which could prove useful in the future.
Pranoprofen, brand name Niflan, belongs to a class of medications called nonsteroidal anti-inflammatory drugs (NSAID). Niflan can block the synthesis of prostaglandins by inhibiting cyclooxygenase, an enzyme converting arachidonic acid to cyclic endoperoxides, precursors of prostaglandins (49) . Cytokines and prostaglandins are well-known inflammatory mediators in the brain, and their biosynthesis is enhanced following seizures (49) . Dorzolamide hydrochloride is an inhibitor of carbonic anhydrases (CA), enzymes known to catalyze reversible hydration/dehydration of CO2/HCO3(-), respectively. CA inhibitors can reduce seizures through perturbation of the CO2 equilibrium and/or the inhibition of ion channels (50) . Acetazolamide, a carbonic anhydrase inhibitor, is primarily used in combination therapy with other antiepileptic medications in both children and adults (50) (51) (52) . Our findings support the use of dorzolamide hydrochloride as a potential anti-epileptic drug specifically for individuals with seizure caused by Dup15q syndrome.
Vital dyes like brilliant vital red (53) and methyl blue IV (54) have been proposed as anti-convulsive agents as far back as the 1930s.The prevailing hypothesis was that these dyes worked by rendering the blood-brain barrier impermeable to "convulsive toxins" in the systemic circulation (55) . Recently, methylene blue has been found to be an anti-convulsant during self-sustaining status epilepticus (SSSE) induced by prolonged basolateral amygdala stimulation (BLA) in Wistar rats (56) . Although speculative, it is possible that the contrast agent or dye Iopamidol, identified in our screen as a suppressor of seizures (Figure 2) , might function in a similar manner.
Advantages of using a Drosophila Model for Dup15q Seizure Suppressor Screening
Screening for compounds using a Drosophila model of a human disorder is not unprecedented. It has been clear for some time that genes across the fly genome show significant homology to human genes when associated with human disease etiology (57) .
Moreover, recent efforts have illustrated the use of Drosophila to quickly evaluate new disease associated variants in vivo (58) (59) (60) and compound screens have produced important new drugs for treating human conditions ranging from cancer to kidney stones (61) (62) (63) , as well as nervous system conditions (64) . In this study, for example, all of the genes in both serotonin and dopamine signaling, as well as the UBE3A gene, show high DIOPT scores of homology (65) to their human counterparts (Table S3) . Functional studies in Drosophila support the idea that these basic neurotransmitter-signaling pathways are highly conserved from flies to humans as well (66) (67) (68) . Finally, although several mouse models of Dup15q syndrome have been made, none of these mice show the spontaneous seizures found in patients, but our fly model does recapitulate the seizure sensitivity phenotype (17) . Even if these mouse models did show a seizure phenotype, it would be practically impossible to screen 1280 compounds in a short period of time as we have done here.
One of the limitations of our Dup15q model, however, is that we are unable to do extensive behavior analysis, other than bang sensitivity, primarily because these flies are weak and very sensitive to seizure induction. Although we have shown recently that we can identify genes which affect ASD-like behaviors in flies (69) including repetitive behaviors (grooming), social communication (mating latency) and social spacing (social interaction) we are unable to utilize these behavior tests to explore the ASD aspects of Dup15q syndrome in our current fly model.
Future Studies in Humans with Dup15q and Pharmacoresistant Seizures
Recently, our group identified an EEG biomarker in children with Dup15q syndrome, which has now been confirmed in other cohorts by high density EEG analysis (8, 70) . This biomarker could potentially be used to assess the effects of treating children with Dup15q syndrome with 5-HT1A agonists like vortoxitene in an off-label trial for seizure suppression in these children. Additionally, our other validated drugs have shown more effective seizure suppression in both male and female flies, than the routinely used medications for Dup15q patients (16) and refractory seizures (71), (72) (Figure S5) . Given the hint of success that treatment of non-syndromic epilepsy results in a decrease in seizure frequency when patients are given drugs for anxiety or depression (73) , this study could significantly benefit the Dup15q community by providing a new, safe and a more effective method of decreasing seizure frequency. Table 1 . Primary Screen Hits. Percent suppression is the percentage of flies expressing Dube3a in glia that were not seizing. *Only one representative DMSO vial is shown here.
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For more extensive DMOS data in males and females see Figure S1 .
Table 2. Serotonin Receptor Agonists/Antagonists and Predicted Effects on
Seizure. ATPa levels in glia. The increase in K + levels at the synapse leads to hyperpolarized neurons and pre-disposes these neurons to epileptiform activity. C) Here we have shown that a combination of 5HT and L-dopa can significantly suppress seizures in repo>Dube3a animals despite low levels of ATPa and increased Dube3a in glia. The primary method of this suppression is through the restoration of K + imbalance. We have also documented a restoration of K + levels in glial cells of the brain in the presence of 5HT + L-dopa. Here we propose a mechanism by which both 5HT and L-dopa can activate PKA, which in turn, activates residual ATPa within the glial membrane. Table S1 . All validated compound descriptions. 
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